XML 38 R2.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated income statement - EUR (€)
€ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Consolidated income statement      
Revenue € 796,967 € 781,426 € 751,448
Cost of Revenue (682,086) (606,375) (577,383)
Gross profit 114,881 175,051 174,065
Operating income (expenses)      
Research and development (50,857) (68,529) (76,642)
Selling, general and administrative (188,201) (169,610) (156,190)
Other operating income 52,700 64,793 81,582
Other operating expenses (16,116) (44,202) (1,965)
Impairments of intangible assets   (5,011)  
Reorganization costs (54,930) 0 0
Total operating income (expenses) (257,403) (222,558) (153,215)
Operating income (loss) (142,522) (47,507) 20,850
Non-operating income (expense)      
Gain (loss) on investment in financial instruments reevaluation (38,513) (9,143) (172,159)
Share of profit (loss) and reevaluation of at-equity investments (4,312) (20,752) (15,098)
Other financial income 2,435 9,263 8,336
Other financial expense (11,699) (11,739) (13,150)
Other non-operating income (expense) 636 (714) 12,357
Gain from Bargain Purchase     4,908
Net Income (loss) before taxes (193,977) (80,593) (153,957)
Income taxes (2,102) (3,320) (21,698)
Net income (loss) € (196,078) € (83,913) € (175,655)
Weighted average shares outstanding 177,295,234 176,916,663 176,674,341
Net income per share (basic) € (1.11) € (0.47) € (0.99)
Net income per share (diluted) € (1.11) € (0.47) € (0.99)